|
|
Office Locations:
|
3388 Massachusetts Avenue
Washington, DC 20024
Phone: 202-690-2620
Fax: 607-266-9267
| | |
|
|
|
|
|
Communications & Networking
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
Medical Device
|
|
|
|
Cayuga Venture Fund (CVF), based in Ithaca, New York, has been providing capital and other resources to advanced technology and high growth companies in New York State since 1994. With the late 2005 launch of Cayuga's third fund, the firm will continue to provide these resources to companies commercializing high value technologies, particularly those generated at Cornell University. CVF's primary investment focus is early stage and follow on rounds of financing in technology-based companies with high growth potential in upstate New York or those that have a significant Cornell connection. The firm targets companies in areas such as telecommunications, data communications, semiconductor manufacturing, advanced materials processing and manufacturing, information management, biotechnology, life sciences and nanotechnology.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
